Aspirin, Heparin and Miscarriage

University of Khartoum

Status and phase: Unknown; Phase 4

Conditions: Miscarriage; Pregnancy

Treatments: Drug: Heparin; Drug: Aspirin

Study type: Interventional

Funder types: Other

Identifiers

NCT01917799

LDA and LMWH

Details and patient eligibility

About

Efficacy of low dose aspirin (LDA) versus LDA plus low-molecular-weight-heparin (LMWH) in patients with a history of recurrent miscarriages.

Enrollment: 150 estimated patients

Sex: Female

Ages: 15 to 48 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Pregnant women
• History of 2 or more of miscarriage

Exclusion criteria

• Twins

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

150 participants in 2 patient groups

Aspirin

Experimental group

Description:

75mg tab of aspirin once daily

Treatment:

Drug: Aspirin

Aspirin + heparin

Active Comparator group

Description:

75mg tab of aspirin once daily + 0.4 mL/day of injection of low molecular weight heparin

Treatment:

Drug: Aspirin

Drug: Heparin